Trading Options with an Edge
Select Page

FENC

Search by
TICKER SYMBOL

Fennec Pharmaceuticals Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

7.18

-0.65

(-8.301%)

Volume:

361,639

52 week range:

3.82 - 10.08

Market Cap:

187.243M

Company Description:

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development of PEDMARK™ for the prevention of platinum-induced ototoxicity in pediatric patients. Further, PEDMARK has received Orphan Drug Designation in the U.S. for this potential use. Fennec has a license agreement with Oregon Health and Science University (OHSU) for exclusive worldwide license rights to intellectual property directed to sodium thiosulfate and its use for chemoprotection, including the prevention of ototoxicity induced by platinum chemotherapy, in humans.